The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC).
 
Barbara Burtness
Honoraria - AstraZeneca
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; ALX Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; GlaxoSmithKline; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck
 
Alexander Deneka
No Relationships to Disclose
 
Yasmine Baca
No Relationships to Disclose
 
Ilya Serebriiskii
No Relationships to Disclose
 
Mitchell I. Parker
No Relationships to Disclose
 
Emmanuelle Nicolas
No Relationships to Disclose
 
Jong Woo Lee
No Relationships to Disclose
 
Trisha Wise-Draper
Consulting or Advisory Role - Shattuck Labs
Research Funding - AstraZeneca; Bristol-Myers Squibb; Caris Life Sciences (Inst); GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - AstraZeneca; Bexion; Bristol-Myers Squibb; Caris MPI; Lilly; Merck; Tesaro
 
Ammar Sukari
Stock and Other Ownership Interests - Immunomedics
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Eisai; Merck
Research Funding - Eisai (Inst)
 
Bradley G. Somer
No Relationships to Disclose
 
Erica Golemis
No Relationships to Disclose